CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO

New from Cerilliant - Certified Spiking Solutions® of the nicotine nitrosamine internal standards, 4-(Methylnitrosamine)-1-(3-pyridyl)-1-butanone-13C6 (NNK-13C6) and 4-(Methylnitrosamine)-1-(3-pyridyl)-1-butanol- 13C(NNAL-13C6).

4-(Methylnitrosamine)-1-(3-pyr N-091
100 µg/mL in Methanol

This certified Snap-N-Spike® solution is suitable for use as an internal standard for quantification of NNAL levels in urine or other matrices for nicotine testing by LC-MS/MS or GC/MS. NNAL is a metabolite of NNK or 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone. Measurement of NNAL levels in urine is a reliable way to determine NNK exposure in smokers, non-smokers exposed to environmental tobacco smoke (ETS), or users of smokeless tobacco products such as chewing tobacco or snuff.

4-(Methylnitrosamine)-1-(3-pyr N-092
100 µg/mL in Methanol

Also known as nicotine-derived nitrosamine ketone, NNK is a potent carcinogen and biomarker of exposure to cigarette smoke. NNK, produced upon the curing of tobacco, is found in a variety of tobacco products including chewing tobacco, snuff, cigarettes, and cigars. This stable-labeled internal standard is suitable for use in LC-MS/MS or GC/MS applications in nicotine testing, environmental monitoring, or clinical and diagnostic testing of nicotine biomarkers. 

Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO 17034 and ISO/IEC 17025 & certified ISO 9001.

All New Product Announcements

© 2021 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
MilliporeSigma is a business of Merck KGaA, Darmstadt, Germany
Products | News/Events | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact
Follow Us: Cerilliant Linkedin LinkedIn